Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Veeva SystemsVEEV -1.01%82 Return-on-Tangible-Asset is 12.21% as of Apr. 2026, which is 12% below its 10-year median of 13.86. GuruFocus rates VEEV with a GF Score™ of 82/100 and a GF Value™ of $288.89 (Significantly Undervalued). The stock has 1 warning sign investors should review. Among 683 Healthcare Providers & Services companies, Veeva Systems ranks better than 86.24% on this metric.
Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Veeva Systems's annualizedNet Income for the quarter that ended in Apr. 2026 was $1,044 Mil. Veeva Systems's average total tangible assets for the quarter that ended in Apr. 2026 was $8,548 Mil. Therefore, Veeva Systems's annualized Return-on-Tangible-Asset for the quarter that ended in Apr. 2026 was 12.21%.
The historical rank and industry rank for Veeva Systems's Return-on-Tangible-Asset or its related term are showing as below:
VEEV'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: 10.85 Med: 13.86 Max: 18.63
Current: 11.91
During the past 13 years, Veeva Systems's highest Return-on-Tangible-Asset was 18.63%. The lowest was 10.85%. And the median was 13.86%.
VEEV's Return-on-Tangible-Asset is ranked better than 86.24% of 683
companies
in the Healthcare Providers & Services industry
Industry Median: 2.43
vs VEEV: 11.91
Veeva Systems (NYSE:VEEV) Return-on-Tangible-Asset Explanation
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
Veeva Systems Return-on-Tangible-Asset Related Terms
Veeva Systems Return-on-Tangible-Asset Historical Data
* Premium members only.
The historical data trend for Veeva Systems's Return-on-Tangible-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
VEEV vs BTSG, TEM, HQY: Return-on-Tangible-Asset Comparison
For the Health Information Services subindustry, Veeva Systems's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Veeva Systems Return-on-Tangible-Asset vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Veeva Systems's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where Veeva Systems's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Apr. 2026) net income data.
What does a Return-on-Tangible-Asset of 12.21% mean?
Veeva Systems (VEEV) has a Return-on-Tangible-Asset of 12.21% as of Apr. 2026. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Veeva Systems and its competitors. This is 12% below median its historical median of 13.86. Over the past decade, Veeva Systems' Return-on-Tangible-Asset has ranged from 10.85 to 18.63. According to the industry distribution chart, Veeva Systems ranks #94 out of 683 companies in the Healthcare Providers & Services industry, placing it in the top 13.8%.
Is Veeva Systems' Return-on-Tangible-Asset too high?
Veeva Systems' current Return-on-Tangible-Asset of 12.21% is 12% below median its 10-year median of 13.86. Over the past 10 years, this metric has ranged from a low of 10.85 to a high of 18.63. The Healthcare Providers & Services industry median Return-on-Tangible-Asset is 2.43. Veeva Systems' value of 12.21% is 402.5% above this industry median. Based on the distribution chart, Veeva Systems ranks #94 out of 683 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Veeva Systems has a GF Score™ of 82/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Veeva Systems' Return-on-Tangible-Asset compare to BTSG and TEM?
According to the Healthcare Providers & Services industry distribution chart, Veeva Systems ranks #94 out of 683 companies for Return-on-Tangible-Asset. This places Veeva Systems in the top 14% of its industry — outperforming the majority of peers. The industry median Return-on-Tangible-Asset is 2.43. Veeva Systems' value of 12.21% is 402.5% above this benchmark. Historically, Veeva Systems' own Return-on-Tangible-Asset has ranged from 10.85 to 18.63 over the past decade. While the company's 10-year median is 13.86 vs. the industry median of 2.43, Veeva Systems has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Healthcare Providers & Services company?
The median Return-on-Tangible-Asset among Healthcare Providers & Services companies is 2.43, based on 683 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Veeva Systems's current Return-on-Tangible-Asset of 12.21% is 402.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Veeva Systems and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Asset is 2.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Veeva Systems's current Return-on-Tangible-Asset is 12.21%, which is 12% below median its own 10-year median of 13.86. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Veeva Systems stock overvalued right now?
Based on GuruFocus' analysis, Veeva Systems (VEEV) is currently considered Significantly Undervalued. The stock's GF Value™ is $288.89, compared to a current price of $195.38 — trading 32.4% below its estimated fair value. The current Return-on-Tangible-Asset is 12.21%, which is 12% below median its 10-year median of 13.86 and 402.5% above the Healthcare Providers & Services industry median of 2.43. Veeva Systems' overall GF Score™ is 82/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For Veeva Systems (VEEV), the current Return-on-Tangible-Asset is 12.21% as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Veeva Systems (VEEV) Overvalued in 2026?
Based on GuruFocus' analysis, Veeva Systems stock appears to be undervalued.
The current stock price of $195.38 is trading 32.4% below its estimated GF Value™ of $288.89.
GuruFocus considers Veeva Systems to be Significantly Undervalued.
Key valuation signals for VEEV:
Return-on-Tangible-Asset: 12.21% (12% below median its 10-year median of 13.86)
GF Value™: $288.89 vs. price of $195.38 (32.4% below fair value)
Industry Position: 402.5% above the Healthcare Providers & Services median (#94 of 683)
No single metric tells the full story. See the VEEV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company's best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company.
82GF Score
Get the complete analysis for VEEV
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
VEEV has been successfully added to your 
